Ads
related to: new hep c drugs
Search results
Results from the WOW.Com Content Network
Sofosbuvir is also used with other medications and longer treatment durations, depending on specific circumstances, genotype and cost-effectiveness–based perspective. For example, for the treatment of genotypes 1, 4, 5, and 6 hepatitis C infections, sofosbuvir can be used in combination with the viral NS5A inhibitor ledipasvir. [16]
In fact, the rate of new hepatitis C cases more than quadrupled over the last decade, ... including heroin” or other needle drugs, he says. The scary news: Untreated, hepatitis C can be fatal ...
Elbasvir/grazoprevir, sold under the brand name Zepatier, is a fixed-dose combination for the treatment of hepatitis C, containing elbasvir (an inhibitor of hepatitis C virus's NS5A protein) and grazoprevir (an NS3/4A inhibitor). It is used to treat chronic hepatitis C virus (HCV) genotypes 1 or 4 infection in both treatment-naïve and ...
More severe reactions are connected with allergic reactions to the medications and cardiovascular problems. Harvoni side effects are considered relatively mild compared to older interferon-based treatment. [citation needed] Ledipasvir/sofosbuvir could cause hepatitis B re-activation in people co-infected with hepatitis B and C viruses.
Bristol-Myers Squibb's (NYS: BMY) latest data on its current hepatitis C drugs explain why the pharma needed to purchase Inihibitex (NAS: INHX) . A combination of its drugs -- daclatasvir and ...
It has been a rough five days for Vertex Pharmaceuticals. The FDA placed a partial clinical hold on a key next-generation hepatitis-C drug at the end of last week, and this week's second-quarter ...
Ads
related to: new hep c drugs